4//SEC Filing
MCKENZIE W THORPE 4
Accession 0001209191-22-003158
CIK 0001626878other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 12:18 PM ET
Size
8.7 KB
Accession
0001209191-22-003158
Insider Transaction Report
Form 4
XBiotech Inc.XBIT
MCKENZIE W THORPE
Director10% Owner
Transactions
- Exercise/Conversion
Stock Option
2021-12-16−250,000→ 320,000 totalExercise: $10.00From: 2011-12-31Exp: 2021-12-30→ Common Stock (250,000 underlying) - Exercise/Conversion
Common Stock
2021-12-16$10.00/sh+250,000$2,500,000→ 2,810,964 total - Tax Payment
Common Stock
2021-12-16$11.71/sh−213,493$2,500,003→ 2,597,471 total
Footnotes (1)
- [F1]Represents a "net exercise" of outstanding stock options. The reporting person received 36,507 shares of common stock on net exercise of option to purchase 250,000 shares of common stock. The Company withheld 213,493 shares of common stock underlying the option for payment of the exercise price using the closing stock price on December 16, 2021 of $11.71, pursuant to the terms of the 2005 Equity Incentive Plan.
Documents
Issuer
XBiotech Inc.
CIK 0001626878
Entity typeother
Related Parties
1- filerCIK 0001211462
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 12:18 PM ET
- Size
- 8.7 KB